GILEAD SCIENCES, INC. Insider Trading Activity
Gilead Sciences officer Johanna Mercier, Chief Commercial & Corporate Affairs Officer, reported performance-based stock awards on common shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Gilead Sciences officer Johanna Mercier, Chief Commercial & Corporate Affairs Officer, reported performance-based stock awards on common shares. On February 3, 2026, she acquired 44,867 shares at $0 following certification that performance goals were met for awards granted in March 2023 and March 2024.
On the same date, 24,800 shares were withheld at $143.28 per share, likely for tax obligations, leaving her with 123,288 shares of Gilead common stock held directly. Portions of the 2024 award will be issued only after additional service requirements are satisfied.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 44,867 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 24,800 | $143.28 | $3.55M |
Footnotes (1)
- F1. Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on March 10, 2023 and March 10, 2024. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors. However, the shares certified for grants made March 10, 2024 will not be issued to the Reporting Person until the requisite continuing service requirements are also met.
AI-generated analysis. How Rhea-AI works. Not financial advice.